Influence coronary collateral vessels myocardial infarct size humans Results phase myocardial infarction TIMI trial TIMI Investigators BACKGROUND influence coronary collateral vessels infarct size humans controversial previous study impact collaterals present onset acute myocardial infarction infarct size METHODS RESULTS present study data base Thrombolysis Myocardial Infarction TIMI Phase trial presence absence collaterals initial hours myocardial infarct evolution size infarct serial measurements serum creatine kinase CK confounding effects reperfusion enzymatic estimates infarct size report patients minutes administration tissue plasminogen activator streptokinase Patients collaterals group values peak serum CK patients collaterals group versus IU/l mean SEM CK-derived infarct size estimates group group versus CK gram equivalents infarct size patients collaterals anterior infarctions infarctions locations beneficial effects collaterals independent site infarct patients ventricular ejection fraction LVEF contrast ventriculography initial cardiac catheterization thrombolytic therapy hospital discharge patients studies global LVEF pretreatment discharge group group patients hospital discharge global LVEF patients coronary collaterals versus CONCLUSIONS results patients thrombolytic therapy reperfusion presence coronary collateral vessels onset myocardial infarction limitation infarct size improved ventricular function discharge LVEF 